Syed, Yahiya Y.
Article History
First Online: 26 June 2018
Change Date: 6 August 2018
Change Type: Correction
Change Details: Following a once-daily on days 1–14 of each 21-day cycle regimen, plasma concentrations of anlotinib reached maximum on day 14 and decreased subsequently with the 7-day rest period until the start of the next treatment cycle [2].
Compliance with Ethical Standards
:
: The preparation of this review was not supported by any external funding.
: During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from any comments received were made by the author on the basis of scientific completeness and accuracy. Yahiya Y. Syed is a salaried employee of Adis/Springer, is responsible for the article content and declares no relevant conflicts of interest.